GSK plc American Depositary Shares (Each representing two Ordina GSK
Open calendar →GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Company · NYSE
USD closing-price chart (daily close from yfinance · Last year)
USD 37.02 → 50.76 · 37.1%
Numbered dotted lines mark the filtered filings under Announcement Events below.
Price & SEC Filing History 22 Jul 2025 — 23 Jul 2026 (Last year)
Daily NYSE prices are sourced from yfinance. Yellow highlighting marks an intraday rise or a gap up between adjacent trading sessions. SEC acceptance times are converted to US Eastern time: pre-market filings appear below that day’s OHLCV row; filings accepted after the 09:30 ET open appear above it. The SEC does not publish an exact first-public-availability timestamp, so acceptance time is the best available proxy.
Date
Open
High
Low
Close
Volume
No data yet
99 · 6-K
After market open · 12:52 ET
JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS ↗
51.7300
51.8300
50.6800
50.7600
3,686,105
50.2600
51.3100
50.1600
50.7800
3,901,400
98 · 6-K
After market open · 10:13 ET
BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE ↗
51.3800
51.6700
50.0100
50.0400
5,345,200
Weekend
Weekend
51.0700
52.2700
51.0400
51.7600
10,759,700
97 · 6-K
Pre-market · 07:14 ET
AUDIT TENDER CONCLUSION ↗
96 · 6-K
Pre-market · 06:50 ET
CAMLIPIXANT PHASE III RESULTS UPDATE ↗
95 · 6-K
After market open · 10:45 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.4800
52.8500
51.4000
52.7700
3,978,500
51.2200
51.8200
51.0800
51.4500
2,800,200
94 · 6-K
Pre-market · 09:11 ET
GSK COMPLETES ACQUISITION OF NUVALENT, INC ↗
93 · SC TO-T/A
Pre-market · 09:00 ET
SC TO-T/A ↗
92 · 6-K
After market open · 11:20 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.8200
51.9500
51.0500
51.2500
3,315,300
91 · 6-K
After market open · 11:28 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.9700
52.6800
51.7500
52.2900
2,050,800
90 · 6-K
Pre-market · 06:29 ET
POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER ↗
Weekend
Weekend
52.9800
53.0600
52.3100
52.7800
2,867,700
89 · 6-K
Pre-market · 08:13 ET
HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ ↗
88 · SC TO-T/A
Pre-market · 08:44 ET
SC TO-T/A ↗
87 · 6-K
After market open · 11:27 ET
DIRECTOR/PDMR SHAREHOLDING ↗
52.5500
52.8500
52.3000
52.4700
2,358,100
86 · 6-K
Pre-market · 07:27 ET
DIRECTORATE CHANGE ↗
52.6800
53.0200
52.4600
52.5200
3,083,500
85 · SC TO-T/A
After-hours · 16:44 ET
SC TO-T/A ↗
54.1500
54.2900
53.1400
53.3200
3,673,200
53.8000
53.8000
52.4500
53.0900
3,776,800
Weekend
Weekend
No trading
52.4200
53.8400
52.2500
53.6600
3,802,600
84 · 6-K
After market open · 10:02 ET
TOTAL VOTING RIGHTS ↗
52.2000
52.2500
51.0800
51.3000
3,202,600
52.5900
52.6900
51.5100
52.4200
4,011,100
83 · 6-K
After market open · 10:25 ET
TRANSACTION IN OWN SHARES ↗
82 · 6-K
After market open · 10:20 ET
HOLDING(S) IN COMPANY ↗
52.4800
52.9300
52.1100
52.8100
4,183,300
Weekend
Weekend
81 · 6-K
After market open · 10:02 ET
HOLDING(S) IN COMPANY ↗
51.6400
52.7200
51.6100
52.5000
4,205,000
51.9600
52.4800
51.7200
51.8900
3,575,400
80 · 6-K
After market open · 10:46 ET
DIRECTOR/PDMR SHAREHOLDING ↗
79 · 6-K
After market open · 10:39 ET
GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT ↗
78 · SC TO-T/A
After-hours · 16:03 ET
SC TO-T/A ↗
52.1500
52.2000
51.0200
51.0900
3,669,900
77 · SC TO-T
Pre-market · 07:15 ET
SC TO-T ↗
76 · 6-K
After market open · 11:05 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.6300
52.1200
51.5100
52.0700
3,008,300
75 · 6-K
After market open · 11:00 ET
TRANSACTION IN OWN SHARES ↗
50.7900
51.1800
50.5900
50.7400
3,735,200
Weekend
Weekend
No trading
51.7900
51.9400
50.4300
50.6700
4,219,100
74 · 6-K
After market open · 12:02 ET
CUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDA ↗
52.4800
52.8200
51.7900
52.1500
4,016,800
52.6200
52.7200
52.0100
52.2200
3,853,900
73 · 6-K
After market open · 10:02 ET
TRANSACTION IN OWN SHARES ↗
52.9300
53.2100
52.1700
52.2300
3,434,100
Weekend
Weekend
53.1300
53.4500
52.8900
53.0400
3,805,900
72 · 6-K
Pre-market · 06:32 ET
MOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXAS ↗
71 · 6-K
After market open · 10:42 ET
DIRECTOR/PDMR SHAREHOLDING ↗
52.1800
53.2100
52.0800
52.8600
5,018,400
70 · 6-K
After market open · 10:36 ET
DIRECTOR/PDMR SHAREHOLDING ↗
69 · SC TO-C
After-hours · 16:54 ET
SC TO-C ↗
51.3200
51.6200
50.9900
51.1700
5,075,900
68 · 6-K
After market open · 13:37 ET
DR HAL BARRON - NEW DIRECTORSHIP ↗
66 · SC TO-C
After-hours · 17:20 ET
SC TO-C ↗
50.4300
51.3400
50.3500
51.2500
6,115,400
67 · 6-K
Pre-market · 06:18 ET
GSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC. ↗
65 · SC TO-C
Pre-market · 07:13 ET
SC TO-C ↗
64 · 6-K
After-hours · 16:08 ET
TRANSACTION IN OWN SHARES ↗
50.9900
51.3800
50.4600
50.6400
4,836,400
Weekend
Weekend
51.4200
51.9700
51.2700
51.5200
4,048,100
50.8100
51.2700
50.7100
51.2700
3,894,000
49.4700
49.8900
49.3900
49.7200
3,811,700
48.9500
49.3600
48.5700
49.0000
2,942,000
63 · 6-K
After market open · 10:46 ET
TOTAL VOTING RIGHTS ↗
62 · 6-K
After market open · 10:00 ET
TRANSACTION IN OWN SHARES ↗
49.9800
50.1400
49.1800
49.3100
4,073,400
Weekend
Weekend
51.0700
51.2600
50.5100
50.5400
2,797,600
51.3500
51.9400
51.2100
51.2400
3,965,300
61 · 6-K
Pre-market · 06:02 ET
POSITIVE PHASE 3 DATA FOR BEPIROVIRSEN ↗
60 · 6-K
After market open · 10:34 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.7800
52.1100
51.5500
51.5800
3,066,600
59 · 6-K
After market open · 10:23 ET
ADMISSION TO TRADING ↗
58 · 6-K
After market open · 10:17 ET
TRANSACTION IN OWN SHARES ↗
51.8700
51.9000
51.1200
51.5000
2,835,500
No trading
Weekend
Weekend
51.5600
51.8000
51.1400
51.3800
3,153,600
57 · 6-K
Pre-market · 07:19 ET
Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026 ↗
50.8400
51.7700
50.5900
51.5300
2,102,400
56 · 6-K
After market open · 10:40 ET
DIRECTOR/PDMR SHAREHOLDING ↗
55 · 6-K
After market open · 10:39 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.1400
51.2700
50.6800
50.7800
2,898,700
54 · 6-K
After market open · 11:01 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.4200
51.2600
50.4100
51.0500
3,834,700
53 · 6-K
After market open · 11:03 ET
TRANSACTION IN OWN SHARES ↗
49.7900
50.5300
49.7900
50.2600
3,108,000
52 · 6-K
Pre-market · 06:29 ET
JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR ↗
Weekend
Weekend
50.1500
50.2500
49.3900
49.6700
3,915,000
51 · 6-K
After market open · 12:22 ET
DIRECTOR/PDMR SHAREHOLDING ↗
51.2400
51.3100
50.7900
50.9600
3,536,000
50.3300
51.2500
50.2500
50.9900
4,114,200
50.5400
51.1900
50.3400
50.9000
4,848,600
50 · 6-K
After market open · 10:59 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.6500
50.9200
49.7100
49.8100
3,575,200
49 · 6-K
Pre-market · 06:42 ET
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN ↗
48 · 6-K
Pre-market · 06:31 ET
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME ↗
Weekend
Weekend
50.5100
50.5700
50.0500
50.4100
2,409,300
50.8200
50.8200
50.4200
50.5000
3,403,300
47 · 6-K
After market open · 13:52 ET
RESULT OF AGM ↗
51.0900
51.2200
50.5200
50.5300
3,897,600
46 · 6-K
After market open · 12:54 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.4500
50.6500
50.0200
50.3800
3,521,800
51.5200
51.6100
50.7900
50.9000
3,202,800
Weekend
Weekend
45 · 6-K
After market open · 11:11 ET
TOTAL VOTING RIGHTS ↗
44 · 6-K
After market open · 11:08 ET
HOLDING(S) IN COMPANY ↗
51.8000
52.2300
51.5200
51.6100
3,938,100
51.9100
52.6300
51.6300
52.3100
5,147,900
43 · 6-K
After market open · 12:00 ET
DIRECTOR/PDMR SHAREHOLDING ↗
50.0000
52.1300
49.9900
51.4000
11,238,500
42 · 6-K
Pre-market · 08:09 ET
1ST QUARTER RESULTS ↗
41 · 6-K
After market open · 11:18 ET
DIRECTOR/PDMR SHAREHOLDING ↗
54.3700
55.0200
54.1800
54.4700
6,751,700
40 · 6-K
Pre-market · 07:24 ET
BEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCE ↗
54.2100
54.7900
54.1800
54.2200
3,084,600
39 · 6-K
Pre-market · 08:13 ET
EFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONS ↗
38 · 6-K
Pre-market · 06:58 ET
TESARO UPDATE ON ANAPTYSBIO INC. LITIGATION ↗
Weekend
Weekend
37 · 6-K
After market open · 11:20 ET
DIRECTOR/PDMR SHAREHOLDING ↗
55.2200
55.2700
54.1900
54.4400
5,048,800
55.9800
56.1900
55.5100
55.6300
3,454,000
36 · 6-K
Pre-market · 06:03 ET
TRANSACTION IN OWN SHARES ↗
56.2900
56.3400
55.6800
55.7000
3,584,500
35 · 6-K
Pre-market · 06:06 ET
TRANSACTION IN OWN SHARES ↗
56.4800
56.5100
55.9500
56.1200
3,998,800
34 · 6-K
Pre-market · 06:03 ET
TRANSACTION IN OWN SHARES ↗
33 · 6-K
After market open · 12:46 ET
DIRECTOR/PDMR SHAREHOLDING ↗
58.1700
58.2700
57.3000
57.3500
3,662,100
32 · 6-K
Pre-market · 06:37 ET
BLENREP APPROVED IN CHINA FOR 2L+ MULTIPLE MYELOMA ↗
31 · 6-K
Pre-market · 06:19 ET
TRANSACTION IN OWN SHARES ↗
Weekend
Weekend
57.6900
58.3600
57.4300
58.3500
2,986,300
30 · 6-K
Pre-market · 06:16 ET
TRANSACTION IN OWN SHARES ↗
29 · 6-K
After market open · 13:01 ET
DIRECTOR/PDMR SHAREHOLDING ↗
57.6400
57.7800
57.0800
57.1300
3,002,800
28 · 6-K
Pre-market · 06:42 ET
TRANSACTION IN OWN SHARES ↗
59.2800
59.2800
57.4800
57.8100
3,379,300
27 · 6-K
Pre-market · 06:39 ET
GSK COMPLETES ACQUISITION OF 35PHARMA INC. ↗
26 · 6-K
Pre-market · 06:05 ET
TRANSACTION IN OWN SHARES ↗
25 · 6-K
After market open · 11:22 ET
DIRECTOR/PDMR SHAREHOLDING ↗
58.9600
59.5700
58.1400
59.1800
3,753,500
24 · 6-K
Pre-market · 06:45 ET
TRANSACTION IN OWN SHARES ↗
23 · 6-K
After market open · 11:17 ET
DIRECTOR/PDMR SHAREHOLDING ↗
58.3800
58.9800
58.1600
58.9400
4,153,300
22 · 6-K
Pre-market · 06:23 ET
GSK PRESENTS POSITIVE DATA FOR BEHOLD 1 B7 H4 ADC ↗
21 · 6-K
Pre-market · 06:09 ET
TRANSACTION IN OWN SHARES ↗
Weekend
Weekend
20 · 6-K
After market open · 11:54 ET
DIRECTOR/PDMR SHAREHOLDING ↗
59.0500
59.0600
58.1900
58.2100
4,407,500
19 · 6-K
Pre-market · 06:51 ET
TRANSACTION IN OWN SHARES ↗
18 · 6-K
After market open · 12:38 ET
DIRECTOR/PDMR SHAREHOLDING ↗
57.1500
58.6600
57.0100
58.3600
3,465,800
17 · 6-K
Pre-market · 06:28 ET
TRANSACTION IN OWN SHARES ↗
57.0300
57.4100
56.5100
57.3700
3,809,500
16 · 6-K
Pre-market · 08:07 ET
EXDENSUR APPROVED FOR CRSWNP IN CHINA ↗
15 · 6-K
Pre-market · 08:01 ET
TRANSACTION IN OWN SHARES ↗
55.8800
55.9600
55.1100
55.8400
3,845,900
14 · 6-K
Pre-market · 08:22 ET
TRANSACTION IN OWN SHARES ↗
56.6500
56.7600
56.1900
56.3700
2,051,500
Weekend
Weekend
No trading
56.0100
57.1800
55.9300
56.6900
3,877,300
13 · 6-K
Pre-market · 07:35 ET
TRANSACTION IN OWN SHARES ↗
12 · 6-K
After market open · 12:49 ET
DIRECTOR/PDMR SHAREHOLDING ↗
11 · 6-K
After market open · 12:27 ET
TOTAL VOTING RIGHTS ↗
55.5200
56.4600
55.4100
55.9900
6,253,900
10 · 6-K
Pre-market · 06:58 ET
TRANSACTION IN OWN SHARES ↗
9 · 6-K
Pre-market · 06:37 ET
VIIV COMPLETES CHANGES TO MINORITY SHAREHOLDING ↗
54.7400
55.2500
54.3700
55.1900
5,532,300
8 · 6-K
Pre-market · 06:16 ET
TRANSACTION IN OWN SHARES ↗
54.6400
54.6500
54.0700
54.2300
3,361,400
7 · 6-K
Pre-market · 06:50 ET
BEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINA ↗
6 · 6-K
Pre-market · 06:35 ET
EXDENSUR APPROVED FOR SEVERE ASTHMA IN CHINA ↗
5 · 6-K
Pre-market · 06:24 ET
TRANSACTION IN OWN SHARES ↗
Weekend
Weekend
54.2300
54.7500
53.7900
53.8400
3,034,200
4 · 6-K
Pre-market · 07:43 ET
TRANSACTION IN OWN SHARES ↗
3 · 6-K
Pre-market · 07:37 ET
BEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMA ↗
54.5800
54.8800
53.8600
53.9400
6,556,600
2 · 6-K
Pre-market · 07:07 ET
TRANSACTION IN OWN SHARES ↗
1 · 6-K
After market open · 13:07 ET
DIRECTOR/PDMR SHAREHOLDING ↗
54.3900
54.9800
54.0700
54.7000
5,306,100
51.7900
53.1000
51.7100
52.9500
4,778,500
52.1900
52.6900
51.8000
51.9900
4,333,600
Weekend
Weekend
52.1700
52.4000
51.5500
51.8400
4,637,100
51.7200
52.6900
51.6500
52.3700
3,990,400
52.8800
52.8800
51.7800
52.0600
4,654,600
53.7300
53.9900
53.3700
53.4100
3,404,000
54.2100
54.5800
53.7000
53.7700
4,149,000
Weekend
Weekend
54.4800
54.7300
53.3700
53.3900
4,661,200
54.5700
54.5700
53.7700
54.2800
5,329,600
55.3000
55.5600
54.7900
55.1500
5,396,000
55.5300
56.0500
55.1000
55.3200
5,365,300
54.3600
55.5800
53.9200
55.5100
5,966,800
Weekend
Weekend
54.4100
54.9200
54.0700
54.5100
6,192,600
56.0300
56.0800
54.7200
55.2700
6,887,600
57.0200
57.0300
56.2900
56.8300
3,815,100
56.8200
57.3500
56.1600
57.0700
3,913,800
58.5600
58.8700
58.0000
58.2900
3,167,700
Weekend
Weekend
58.4300
59.3600
58.3300
59.1300
5,981,900
59.0000
59.0700
58.0500
58.0700
6,224,200
59.6700
59.9400
59.4900
59.5400
4,627,100
59.5100
59.8200
59.0900
59.1200
5,755,800
59.2700
59.7100
59.0200
59.2600
6,849,200
Weekend
Weekend
59.8700
60.0500
59.3300
59.5200
7,219,700
60.9300
61.0600
59.9800
60.8500
4,868,400
61.5400
61.7000
60.9900
61.1800
5,389,800
60.5000
61.0300
60.0600
60.8700
5,675,100
No trading
Weekend
Weekend
58.8700
59.1700
58.5600
58.9300
6,280,800
58.4300
58.6200
58.0500
58.5400
6,244,500
58.7400
58.9200
58.0200
58.4900
6,951,400
59.2400
59.3200
58.1900
58.8200
9,503,900
59.9200
59.9400
58.6100
59.0100
8,070,900
Weekend
Weekend
59.2900
60.3700
59.2500
60.2300
8,148,900
57.7900
59.6200
57.7300
59.1700
13,085,100
56.5600
57.6200
56.3300
57.2300
10,897,000
52.4900
53.3800
52.4300
53.3400
6,205,900
52.1700
52.6700
52.1300
52.4700
4,151,200
Weekend
Weekend
51.1400
51.6900
51.0600
51.6000
5,489,900
50.8200
51.0900
50.6300
50.6600
5,904,400
50.1700
50.6100
49.6000
50.1000
5,883,400
50.4900
51.3700
50.4900
50.8000
5,105,000
49.7700
50.5700
49.7400
50.3200
4,220,500
Weekend
Weekend
48.7400
49.1600
48.5700
49.1500
5,430,000
48.4100
48.7500
48.0800
48.6500
4,564,500
47.8500
48.3800
47.7700
48.0700
6,516,400
48.0500
48.3500
47.6200
47.6500
8,201,100
No trading
Weekend
Weekend
48.8500
48.9300
48.0900
48.2200
7,543,400
50.4800
50.5000
49.0700
49.1200
6,545,200
50.2000
50.8700
50.1600
50.7900
3,684,100
49.9300
50.0700
49.3200
49.9000
3,693,100
50.8000
50.8200
50.1700
50.3900
2,640,700
Weekend
Weekend
50.4300
50.8100
50.3600
50.3900
3,925,700
50.8000
51.2700
50.0200
50.2200
4,406,900
50.6900
51.3900
50.5600
50.6200
5,205,100
50.6900
51.4600
50.3400
50.5600
5,923,800
49.5000
49.5700
48.5900
49.0200
5,277,900
Weekend
Weekend
49.2300
49.6300
49.0700
49.6300
3,486,000
No trading
49.2000
49.2400
48.9300
49.0400
1,584,800
49.3000
49.4000
49.1400
49.3000
1,833,500
48.9200
49.2400
48.9200
49.1100
1,820,800
Weekend
Weekend
48.9700
49.1300
48.8500
49.0800
1,207,500
No trading
48.7200
49.0400
48.6900
48.9600
1,064,900
48.9900
49.2300
48.7200
48.8500
2,857,600
48.6500
48.8800
48.5000
48.5900
2,602,800
Weekend
Weekend
48.2100
48.9300
48.1500
48.6100
3,286,400
48.4000
48.6900
48.2400
48.2900
3,470,100
49.3500
49.4400
48.6800
48.7100
5,257,600
49.2800
49.3600
48.5200
48.7800
3,800,700
48.9100
49.3900
48.9000
49.2400
4,059,100
Weekend
Weekend
48.9000
48.9900
48.5600
48.8100
2,972,500
48.4600
48.9700
48.4500
48.8800
3,871,100
48.0400
48.4400
47.8200
48.4100
2,988,000
48.0100
48.2900
47.2000
47.2700
3,782,600
48.3900
48.5800
48.1500
48.4700
4,354,000
Weekend
Weekend
48.7700
48.8500
48.0100
48.4100
2,380,400
48.9500
49.0600
48.5300
48.5700
3,326,100
48.9500
49.3100
48.8000
48.9700
3,696,000
48.0900
48.4100
47.7800
48.2700
4,840,400
48.0600
48.0800
47.1300
47.1900
3,663,200
Weekend
Weekend
47.8800
47.9000
47.4200
47.8600
2,851,800
No trading
48.0400
48.3600
47.9800
48.0200
4,282,100
47.3500
47.9200
47.3100
47.5500
6,602,200
47.0300
47.3400
46.8600
46.9900
5,306,100
Weekend
Weekend
46.4900
47.3200
46.4700
47.1900
4,235,300
46.6000
46.6000
45.8100
46.1100
6,208,600
47.0200
47.0800
46.3200
46.3400
6,213,100
47.0300
47.4800
46.9600
47.3700
4,635,000
47.6000
47.9800
47.4200
47.5300
3,735,100
Weekend
Weekend
47.3200
47.5700
47.1000
47.1800
5,054,200
48.0200
48.6900
48.0100
48.1400
4,035,800
47.7600
48.3100
47.5200
48.0700
3,565,900
47.8300
48.4800
47.8200
48.4100
3,916,100
46.7500
47.3700
46.5600
47.3600
2,861,700
Weekend
Weekend
46.7500
46.9300
46.3900
46.6300
5,552,900
46.8400
47.2100
46.6200
47.1000
4,212,600
46.5600
47.0400
46.5200
46.6900
5,525,000
46.0900
47.0200
45.9900
46.8200
5,065,300
46.7500
46.7500
46.2600
46.3500
4,764,800
Weekend
Weekend
46.8500
47.1200
46.5700
46.8600
5,027,400
45.9300
47.1600
45.8200
46.9400
8,724,800
46.0200
46.7100
45.5000
45.9300
13,924,300
44.0000
44.2400
42.8900
43.7000
8,410,100
43.8500
44.2200
43.6500
43.8000
5,573,100
Weekend
Weekend
43.7900
43.9900
42.8500
43.2400
9,860,100
43.9900
46.8700
43.9800
45.5400
7,897,600
44.0600
44.4700
44.0100
44.2600
3,044,500
44.3500
44.4400
43.8300
43.9400
3,909,800
43.8800
44.3100
43.7100
44.1200
3,216,800
Weekend
Weekend
43.3700
44.3500
43.3400
43.9100
4,076,100
43.9700
44.1000
43.6200
43.7700
2,609,700
43.2200
43.9300
43.2200
43.7800
4,551,800
43.8100
44.1700
43.7100
44.1500
3,693,700
43.2400
43.7500
43.2100
43.6900
3,151,500
Weekend
Weekend
43.7600
43.7800
43.1000
43.5400
5,318,600
44.0500
44.2300
43.3800
43.4400
4,429,700
43.7600
43.9000
43.3400
43.3500
2,947,900
43.2600
43.6800
43.0900
43.5000
3,867,500
43.7000
44.0200
43.3500
43.4500
6,465,400
Weekend
Weekend
44.0700
44.2600
43.0400
43.3500
13,115,700
44.7100
44.9600
43.6500
43.6900
13,319,100
44.2200
45.5900
44.1700
45.5100
14,144,200
41.8500
43.3200
41.7500
43.1600
11,695,600
40.4900
41.1000
40.3600
41.1000
7,271,600
Weekend
Weekend
39.9300
40.2300
39.4600
39.8500
4,760,800
40.1600
40.2300
39.2900
39.5200
4,638,100
40.1100
40.3700
39.9200
40.1800
3,285,900
40.9300
40.9300
40.4600
40.5200
3,389,300
40.6500
41.1000
40.5300
40.9100
3,093,500
Weekend
Weekend
40.6400
40.8300
40.5100
40.6700
3,691,400
40.1000
40.3600
40.0500
40.3000
2,019,500
40.2800
40.5300
40.1300
40.3600
3,929,300
40.3000
40.4200
40.0300
40.0500
3,238,700
40.7000
40.8100
40.2400
40.3000
2,793,600
Weekend
Weekend
41.2400
41.3900
40.5000
40.8300
4,742,000
40.9100
41.5300
40.8400
41.4800
2,653,400
40.5400
40.6300
40.3800
40.5000
3,014,100
40.4200
41.0000
40.3400
40.7800
9,420,700
39.7600
40.0800
39.3700
40.0500
2,817,300
Weekend
Weekend
39.8900
40.7100
39.8500
40.5000
6,540,600
39.3600
39.6900
39.1800
39.6100
2,935,700
39.2400
39.7000
39.1700
39.3600
4,207,600
39.1600
39.5300
38.6300
38.9600
4,325,800
No trading
Weekend
Weekend
39.3200
39.6900
39.2100
39.6700
3,591,600
39.8700
39.8800
39.4100
39.4400
4,676,900
39.9100
40.1300
39.7600
39.9100
3,757,900
40.0800
40.0900
39.6100
39.8300
2,280,600
40.1900
40.2400
39.5700
39.6400
1,877,900
Weekend
Weekend
40.3600
40.5700
40.0800
40.1900
3,403,700
40.0900
40.3400
40.0300
40.0800
2,140,000
39.8100
40.5500
39.8100
40.0700
4,492,300
39.1500
39.6300
39.1500
39.6200
3,447,800
39.2400
39.3600
39.0200
39.0700
2,442,400
Weekend
Weekend
38.7200
39.3600
38.7000
39.3600
3,038,500
38.7500
39.2300
38.6400
39.2300
2,705,200
38.7500
39.3300
38.6200
39.1300
3,493,200
37.8800
38.2700
37.8000
38.2200
2,655,500
37.9600
38.2000
37.7100
37.7100
2,605,600
Weekend
Weekend
37.7100
37.9700
37.6700
37.8000
3,409,800
37.1400
37.8000
37.0700
37.5800
3,709,800
37.1400
37.3800
36.7500
36.7500
3,121,300
37.5800
37.6700
37.0900
37.3200
3,405,300
37.1200
37.6800
37.0400
37.6800
3,288,100
Weekend
Weekend
37.6800
37.7800
37.1700
37.5600
3,678,400
37.4600
38.2200
37.0900
37.1500
8,005,800
38.3200
39.1700
38.2600
38.9700
7,846,700
37.4300
37.9100
37.1000
37.6700
6,336,400
37.9600
37.9900
37.3100
37.4500
3,731,500
Weekend
Weekend
37.7100
37.9700
37.5100
37.9700
4,016,800
37.9300
38.3200
37.7700
38.2300
4,735,200
37.1500
38.9000
37.1300
38.0300
13,453,900
36.3500
37.0200
36.3400
37.0200
5,146,600
Announcement Events
Each title opens the filing on the SEC website. Registered users can summarise the filing and up to seven relevant exhibits linked within the same SEC submission.
99
6-K
JIDEYTRO APPROVED IN US FOR CERTAIN LUNG CANCERS (opens SEC filing in a new tab)
After market open · 12:52 ET
Summarise
98
6-K
BEXSERO 1-DOSE BOOSTER EMA FILE ACCEPTANCE (opens SEC filing in a new tab)
After market open · 10:13 ET
Summarise
96
6-K
CAMLIPIXANT PHASE III RESULTS UPDATE (opens SEC filing in a new tab)
Pre-market · 06:50 ET
Summarise
95
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:45 ET
Summarise
94
6-K
GSK COMPLETES ACQUISITION OF NUVALENT, INC (opens SEC filing in a new tab)
Pre-market · 09:11 ET
Summarise
92
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:20 ET
Summarise
91
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:28 ET
Summarise
90
6-K
POSITIVE JEMPERLI DATA IN DMMR/MSI-H RECTAL CANCER (opens SEC filing in a new tab)
Pre-market · 06:29 ET
Summarise
89
6-K
HANSOH POSITIVE PHASE III RESULTS FOR RIZ-REZ (opens SEC filing in a new tab)
Pre-market · 08:13 ET
Summarise
87
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:27 ET
Summarise
83
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:25 ET
Summarise
80
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:46 ET
Summarise
79
6-K
GSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENT (opens SEC filing in a new tab)
After market open · 10:39 ET
Summarise
76
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:05 ET
Summarise
75
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 11:00 ET
Summarise
74
6-K
CUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDA (opens SEC filing in a new tab)
After market open · 12:02 ET
Summarise
73
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:02 ET
Summarise
72
6-K
MOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXAS (opens SEC filing in a new tab)
Pre-market · 06:32 ET
Summarise
71
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:42 ET
Summarise
70
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:36 ET
Summarise
68
6-K
DR HAL BARRON - NEW DIRECTORSHIP (opens SEC filing in a new tab)
After market open · 13:37 ET
Summarise
67
6-K
GSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC. (opens SEC filing in a new tab)
Pre-market · 06:18 ET
Summarise
62
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:00 ET
Summarise
61
6-K
POSITIVE PHASE 3 DATA FOR BEPIROVIRSEN (opens SEC filing in a new tab)
Pre-market · 06:02 ET
Summarise
60
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:34 ET
Summarise
58
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 10:17 ET
Summarise
57
6-K
Q2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026 (opens SEC filing in a new tab)
Pre-market · 07:19 ET
Summarise
56
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:40 ET
Summarise
55
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:39 ET
Summarise
54
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:01 ET
Summarise
53
6-K
TRANSACTION IN OWN SHARES (opens SEC filing in a new tab)
After market open · 11:03 ET
Summarise
52
6-K
JAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIR (opens SEC filing in a new tab)
Pre-market · 06:29 ET
Summarise
51
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:22 ET
Summarise
50
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 10:59 ET
Summarise
49
6-K
COLLABORATION WITH CTTQ FOR BEPIROVIRSEN (opens SEC filing in a new tab)
Pre-market · 06:42 ET
Summarise
48
6-K
GSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMME (opens SEC filing in a new tab)
Pre-market · 06:31 ET
Summarise
46
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:54 ET
Summarise
43
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:00 ET
Summarise
41
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:18 ET
Summarise
40
6-K
BEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCE (opens SEC filing in a new tab)
Pre-market · 07:24 ET
Summarise
39
6-K
EFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONS (opens SEC filing in a new tab)
Pre-market · 08:13 ET
Summarise
38
6-K
TESARO UPDATE ON ANAPTYSBIO INC. LITIGATION (opens SEC filing in a new tab)
Pre-market · 06:58 ET
Summarise
37
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:20 ET
Summarise
33
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:46 ET
Summarise
32
6-K
BLENREP APPROVED IN CHINA FOR 2L+ MULTIPLE MYELOMA (opens SEC filing in a new tab)
Pre-market · 06:37 ET
Summarise
29
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 13:01 ET
Summarise
27
6-K
GSK COMPLETES ACQUISITION OF 35PHARMA INC. (opens SEC filing in a new tab)
Pre-market · 06:39 ET
Summarise
25
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:22 ET
Summarise
23
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:17 ET
Summarise
22
6-K
GSK PRESENTS POSITIVE DATA FOR BEHOLD 1 B7 H4 ADC (opens SEC filing in a new tab)
Pre-market · 06:23 ET
Summarise
20
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 11:54 ET
Summarise
18
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:38 ET
Summarise
16
6-K
EXDENSUR APPROVED FOR CRSWNP IN CHINA (opens SEC filing in a new tab)
Pre-market · 08:07 ET
Summarise
12
6-K
DIRECTOR/PDMR SHAREHOLDING (opens SEC filing in a new tab)
After market open · 12:49 ET
Summarise
9
6-K
VIIV COMPLETES CHANGES TO MINORITY SHAREHOLDING (opens SEC filing in a new tab)
Pre-market · 06:37 ET
Summarise
7
6-K
BEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINA (opens SEC filing in a new tab)
Pre-market · 06:50 ET
Summarise
6
6-K
EXDENSUR APPROVED FOR SEVERE ASTHMA IN CHINA (opens SEC filing in a new tab)
Pre-market · 06:35 ET
Summarise